Microvesicles from the plasma of elderly subjects and from senescent endothelial cells promote vascular calcification

• Published in: Aging (Albany, NY.) Vol. 9; no. 3; pp. 778 - 789
• Main Authors: Alique, Matilde, Ruíz-Torres, María Piedad, Bodega, Guillermo, Noci, María Victoria, Troyano, Nuria, Bohórquez, Lourdes, Luna, Carlos, Luque, Rafael, Carmona, Andrés, Carracedo, Julia, Ramírez, Rafael
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 08.03.2017
• Subjects: Aged; Aged, 80 and over; Aging - pathology; Calcium - metabolism; Cell-Derived Microparticles - pathology; Cells, Cultured; Cellular Senescence; Endothelial Cells - pathology; Humans; Research Paper; Vascular Calcification - metabolism; Vascular Calcification - pathology; Young Adult; senescence; endothelial cells; aging; microvesicles; vascular smooth muscle cells; vascular calcification
• ISSN: 1945-4589; 1945-4589
• DOI: 10.18632/aging.101191

Vascular calcification is commonly seen in elderly people, though it can also appear in middle-aged subjects affected by premature vascular aging. The aim of this work is to test the involvement of microvesicles (MVs) produced by senescent endothelial cells (EC) and from plasma of elderly people in vascular calcification. The present work shows that MVs produced by senescent cultured ECs, plus those found in the plasma of elderly subjects, promote calcification in vascular smooth muscle cells. Only MVs from senescent ECs, and from elderly subjects' plasma, induced calcification. This ability correlated with these types of MVs' carriage of: a) increased quantities of annexins (which might act as nucleation sites for calcification), b) increased quantities of bone-morphogenic protein, and c) larger Ca contents. The MVs of senescent, cultured ECs, and those present in the plasma of elderly subjects, promote vascular calcification. The present results provide mechanistic insights into the observed increase in vascular calcification-related diseases in the elderly, and in younger patients with premature vascular aging, paving the way towards novel therapeutic strategies.